157 related articles for article (PubMed ID: 35678168)
21. Bayesian data fusion: Probabilistic sensitivity analysis for unmeasured confounding using informative priors based on secondary data.
Comment L; Coull BA; Zigler C; Valeri L
Biometrics; 2022 Jun; 78(2):730-741. PubMed ID: 33527348
[TBL] [Abstract][Full Text] [Related]
22. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.
Fewell Z; Davey Smith G; Sterne JA
Am J Epidemiol; 2007 Sep; 166(6):646-55. PubMed ID: 17615092
[TBL] [Abstract][Full Text] [Related]
23. Monte Carlo sensitivity analysis for unmeasured confounding in dynamic treatment regimes.
Rose EJ; Moodie EEM; Shortreed SM
Biom J; 2023 Jun; 65(5):e2100359. PubMed ID: 37017498
[TBL] [Abstract][Full Text] [Related]
24. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.
Stamey JD; Beavers DP; Faries D; Price KL; Seaman JW
Pharm Stat; 2014; 13(1):94-100. PubMed ID: 24446072
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity analysis of treatment effect to unmeasured confounding in observational studies with survival and competing risks outcomes.
Huang R; Xu R; Dulai PS
Stat Med; 2020 Oct; 39(24):3397-3411. PubMed ID: 32677758
[TBL] [Abstract][Full Text] [Related]
26. Bespoke Instruments: A new tool for addressing unmeasured confounders.
Richardson DB; Tchetgen Tchetgen EJ
Am J Epidemiol; 2022 Mar; 191(5):939-947. PubMed ID: 34907434
[TBL] [Abstract][Full Text] [Related]
27. Summarizing causal differences in survival curves in the presence of unmeasured confounding.
Martínez-Camblor P; MacKenzie TA; Staiger DO; Goodney PP; O'Malley AJ
Int J Biostat; 2020 Sep; 17(2):223-240. PubMed ID: 32946418
[TBL] [Abstract][Full Text] [Related]
28. It's not all about residual confounding: a plea for QBA for epidemiologic researchers and educators.
Fox MP; Adrien N; van Smeden M; Suarez E
Am J Epidemiol; 2024 May; ():. PubMed ID: 38754869
[TBL] [Abstract][Full Text] [Related]
29. A flexible, interpretable framework for assessing sensitivity to unmeasured confounding.
Dorie V; Harada M; Carnegie NB; Hill J
Stat Med; 2016 Sep; 35(20):3453-70. PubMed ID: 27139250
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Bias Analysis of the Association between Occupational Radiation Exposure and Ischemic Heart Disease Mortality in UK Nuclear Workers.
de Vocht F; Martin RM; Hidajat M; Wakeford R
Radiat Res; 2021 Dec; 196(6):574-586. PubMed ID: 34370860
[TBL] [Abstract][Full Text] [Related]
31. A simulation-based bias analysis to assess the impact of unmeasured confounding when designing non-randomized database studies.
Desai RJ; Bradley MC; Lee H; Eworuke E; Weberpals J; Wyss R; Schneeweiss S; Ball R
Am J Epidemiol; 2024 May; ():. PubMed ID: 38825336
[TBL] [Abstract][Full Text] [Related]
32. Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.
Vanderweele TJ; Arah OA
Epidemiology; 2011 Jan; 22(1):42-52. PubMed ID: 21052008
[TBL] [Abstract][Full Text] [Related]
33. The Importance of Making Assumptions in Bias Analysis.
MacLehose RF; Ahern TP; Lash TL; Poole C; Greenland S
Epidemiology; 2021 Sep; 32(5):617-624. PubMed ID: 34224472
[TBL] [Abstract][Full Text] [Related]
34. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.
Stürmer T; Rothman KJ; Avorn J; Glynn RJ
Am J Epidemiol; 2010 Oct; 172(7):843-54. PubMed ID: 20716704
[TBL] [Abstract][Full Text] [Related]
35. Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency Surgery.
Moler-Zapata S; Hutchings A; O'Neill S; Silverwood RJ; Grieve R
Value Health; 2023 Aug; 26(8):1164-1174. PubMed ID: 37164043
[TBL] [Abstract][Full Text] [Related]
36. Validity evaluation of indirect adjustment method for multiple unmeasured confounders: A simulation and empirical study.
Byun G; Kim H; Kim SY; Kim SS; Oh H; Lee JT
Environ Res; 2022 Mar; 204(Pt A):111992. PubMed ID: 34487697
[TBL] [Abstract][Full Text] [Related]
37. Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias?
Masarwa R; Platt RW; Filion KB
Paediatr Perinat Epidemiol; 2020 May; 34(3):309-317. PubMed ID: 31916282
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the impact of unmeasured confounding with internal validation data: an example cost evaluation in type 2 diabetes.
Faries D; Peng X; Pawaskar M; Price K; Stamey JD; Seaman JW
Value Health; 2013; 16(2):259-66. PubMed ID: 23538177
[TBL] [Abstract][Full Text] [Related]
39. When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
Franklin JM; Platt R; Dreyer NA; London AJ; Simon GE; Watanabe JH; Horberg M; Hernandez A; Califf RM
Clin Pharmacol Ther; 2022 Jan; 111(1):108-115. PubMed ID: 33826756
[TBL] [Abstract][Full Text] [Related]
40. A probabilistic bias analysis on the magnitude of unmeasured confounding: The impact of driving mileage on road traffic crashes.
Thiesmeier R; Skyving M; Möller J; Orsini N
Accid Anal Prev; 2023 Oct; 191():107144. PubMed ID: 37473524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
